Genmab A/S Stock Nasdaq
Stocks
GMAB
US3723032062
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.87 USD | -1.22% |
|
+6.93% | +0.23% |
| Aug. 10 | Nordic stocks in North America - Astra Zeneca rose 0.9 percent | FW |
| Aug. 07 | Europe's STOXX 600 ends week at all-time high on earnings support, soft US jobs data | RE |
| Market Cap | 119B 18.37B 15.89B 14.87B 13.6B 25.58B 1,750B 26.02B 174B 68.38B 877B 68.95B 67.47B 2,923B | P/E 2026 * |
25.2x | P/E 2027 * | 17.8x |
|---|---|---|---|---|---|
| Enterprise Value | 139B 21.41B 18.53B 17.33B 15.85B 29.83B 2,040B 30.34B 203B 79.71B 1,022B 80.38B 78.65B 3,408B | EV / Sales 2026 * |
4.79x | EV / Sales 2027 * | 3.87x |
| Free-Float |
95.41% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Genmab A/S
| 1 day | -1.22% | ||
| 1 week | +6.93% | ||
| Current month | +6.93% | ||
| 1 month | +3.66% | ||
| 3 months | +16.80% | ||
| Current year | +0.23% |
| 1 week | 28.47 |  | 31.79 |
| 1 month | 27.86 | | 31.79 |
| Current year | 23.62 | | 35.43 |
| 1 year | 21 | | 35.43 |
| 3 years | 17.24 | | 39.53 |
| 5 years | 17.24 | | 49.07 |
| 10 years | 12.1 | | 49.07 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 2010-05-31 | |
Anthony Pagano
DFI | Director of Finance/CFO | 48 | 2020-02-29 |
Rayne Waller
CTO | Chief Tech/Sci/R&D Officer | - | 2024-08-15 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 75 | 2003-10-31 | |
| Director/Board Member | 58 | 2014-12-31 | |
| Director/Board Member | 75 | 2014-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.22% | +6.93% | - | - | 18.45B | |
| +4.21% | +25.62% | +77.96% | +111.62% | 68.12B | |
| +0.50% | +2.95% | +34.94% | +69.77% | 55.18B | |
| +2.78% | +36.66% | +23.00% | +526.16% | 28.63B | |
| +0.57% | +19.05% | +57.08% | +5.18% | 23.99B | |
| -0.93% | +2.45% | -16.89% | -12.86% | 23.53B | |
| -0.35% | +7.18% | +44.14% | -22.28% | 18.45B | |
| -2.04% | +9.24% | +31.14% | +650.71% | 16.44B | |
| +7.26% | +25.47% | +221.03% | +383.67% | 15.83B | |
| -2.05% | -0.13% | +40.40% | +156.84% | 13.4B | |
| Average | +0.87% | +10.15% | +56.98% | +207.65% | 29.28B | |
| Weighted average by Cap. | +1.46% | +11.47% | +54.01% | +169.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 28.96B 4.47B 3.87B 3.62B 3.31B 6.23B 426B 6.34B 42.4B 16.65B 213B 16.79B 16.43B 712B | 33.63B 5.2B 4.5B 4.21B 3.85B 7.24B 495B 7.36B 49.25B 19.34B 248B 19.5B 19.08B 827B |
| Net income | 4.93B 762M 659M 617M 564M 1.06B 72.6B 1.08B 7.22B 2.84B 36.36B 2.86B 2.8B 121B | 7.14B 1.1B 954M 893M 816M 1.54B 105B 1.56B 10.46B 4.11B 52.63B 4.14B 4.05B 176B |
| Net Debt | 19.71B 3.04B 2.63B 2.46B 2.25B 4.24B 290B 4.31B 28.87B 11.33B 145B 11.43B 11.18B 485B | 11.26B 1.74B 1.5B 1.41B 1.29B 2.42B 166B 2.46B 16.49B 6.47B 82.99B 6.53B 6.39B 277B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-10 | $30.87 | -1.22% | 2,255,302 |
| 26-08-07 | $31.25 | +4.76% | 3,507,362 |
| 26-08-06 | $29.83 | +1.95% | 5,234,385 |
| 26-08-05 | $29.26 | +0.83% | 1,404,184 |
| 26-08-04 | $29.02 | +1.19% | 1,320,546 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GMAB Stock
- GMAB Stock
Select your edition
All financial news and data tailored to specific country editions
